One of the pharmaceutical companies of China will sell favipiravir as a potential therapy of the disease.

Chinese pharmaceutical company Zhejiang Hisun Pharmaceutical Co Ltd announced that it has received approval for the sale of favipiravir (favipiravir) as a potential cure for coronavirus COVID-2019. It is reported

The company also pledged to continue the clinical trials of the drug and after the start of sales. On the morning of February 17, worldwide have contracted 71 331 people died – 1776, defeated the disease – 10 991.